An Informatics Consult approach for generating clinical evidence for treatment decisions
By
Alvina Lai,
Wai Hoong Chang,
Constantinos A Parisinos,
Michail Katsoulis,
Ruth M Blackburn,
Anoop D. Shah,
Vincent Nguyen,
Spiros Denaxas,
George Davey Smith,
Tom R Gaunt,
Krishnarajah Nirantharakumar,
Murray P. Cox,
Donall Forde,
Folkert Asselbergs,
Steve Harris,
Sylvia Richardson,
Reecha Sofat,
Richard J.B Dobson,
Aroon Hingorani,
Riyaz Patel,
Jonathan Sterne,
Amitava Banerjee,
Alastair K. Denniston,
Simon Ball,
Neil J Sebire,
Nigam H. Shah,
Graham R Foster,
Bryan Williams,
Harry Hemingway
Posted 15 Jan 2021
medRxiv DOI: 10.1101/2021.01.10.21249331
An Informatics Consult has been proposed in which clinicians request novel evidence from large scale health data resources, tailored to the treatment of a specific patient, with return of results in clinical timescales. However, the availability of such consultations is lacking. We seek to provide an Informatics Consult for a situation where a treatment indication and contraindication coexist in the same patient, i.e., anti-coagulation use for stroke prevention in a patient with both atrial fibrillation (AF) and liver cirrhosis. We examined four sources of evidence for the effect of warfarin on stroke risk (efficacy) or all-cause mortality (safety) from: (i) randomised controlled trials (RCTs), (ii) meta-analysis of prior observational studies, (iii) trial emulation (using population electronic health records (N = 3,854,710) and (iv) genetic evidence (Mendelian randomisation). We developed prototype forms to request an Informatics Consult and return of results in electronic health record systems. We found 0 RCT reports and 0 trials recruiting for patients with AF and cirrhosis. We found broad concordance across the three new sources of evidence we generated. Meta-analysis of prior observational studies showed that warfarin use was associated with lower stroke risk (hazard ratio [HR] = 0.71). In a target trial emulation, warfarin was associated with lower all-cause mortality (HR = 0.61) and ischaemic stroke (HR = 0.27). Mendelian randomisation served as a drug target validation where we found that lower levels of vitamin K1 (warfarin is a vitamin K1 antagonist) are associated with lower stroke risk. A pilot survey with an independent sample of 34 clinicians revealed that 85% of clinicians found information on prognosis useful and that 79% thought that they should have access to the Informatics Consult as a service within their healthcare systems. We identified candidate steps for automation to scale evidence generation and to accelerate the return of results within clinical timescales.
Download data
- Downloaded 99 times
- Download rankings, all-time:
- Site-wide: 121,486
- In health informatics: 460
- Year to date:
- Site-wide: 12,154
- Since beginning of last month:
- Site-wide: 15,556
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!